257 related articles for article (PubMed ID: 26359590)
1. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
Khan J; Hawley A; Rades T; Boyd BJ
J Pharm Sci; 2016 Sep; 105(9):2631-2639. PubMed ID: 26359590
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
Khan J; Rades T; Boyd BJ
Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
[TBL] [Abstract][Full Text] [Related]
3. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
4. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate.
Sassene PJ; Knopp MM; Hesselkilde JZ; Koradia V; Larsen A; Rades T; Müllertz A
J Pharm Sci; 2010 Dec; 99(12):4982-91. PubMed ID: 20574997
[TBL] [Abstract][Full Text] [Related]
5. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
[TBL] [Abstract][Full Text] [Related]
6. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
Keemink J; Mårtensson E; Bergström CAS
Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
[TBL] [Abstract][Full Text] [Related]
7. Addition of Cationic Surfactants to Lipid-Based Formulations of Poorly Water-Soluble Acidic Drugs Alters the Phase Distribution and the Solid-State Form of the Precipitate Upon In Vitro Lipolysis.
Khan J; Rades T; Boyd BJ
J Pharm Sci; 2018 Sep; 107(9):2420-2427. PubMed ID: 29859958
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.
Sassene PJ; Michaelsen MH; Mosgaard MD; Jensen MK; Van Den Broek E; Wasan KM; Mu H; Rades T; Müllertz A
Mol Pharm; 2016 Oct; 13(10):3417-3426. PubMed ID: 27533712
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
Suys EJA; Chalmers DK; Pouton CW; Porter CJH
Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems.
Tran T; Siqueira SDVS; Amenitsch H; Müllertz A; Rades T
J Control Release; 2017 Jun; 255():45-53. PubMed ID: 28365295
[TBL] [Abstract][Full Text] [Related]
11. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
[TBL] [Abstract][Full Text] [Related]
12. Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations.
Alskär LC; Keemink J; Johannesson J; Porter CJH; Bergström CAS
Mol Pharm; 2018 Oct; 15(10):4733-4744. PubMed ID: 30142268
[TBL] [Abstract][Full Text] [Related]
13. Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations.
Stillhart C; Dürr D; Kuentz M
J Pharm Sci; 2014 Apr; 103(4):1194-203. PubMed ID: 24515977
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate.
Griffin BT; Kuentz M; Vertzoni M; Kostewicz ES; Fei Y; Faisal W; Stillhart C; O'Driscoll CM; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2014 Apr; 86(3):427-37. PubMed ID: 24184675
[TBL] [Abstract][Full Text] [Related]
15. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
[TBL] [Abstract][Full Text] [Related]
16. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
Phan S; Salentinig S; Hawley A; Boyd BJ
Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
18. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering.
Warren DB; Anby MU; Hawley A; Boyd BJ
Langmuir; 2011 Aug; 27(15):9528-34. PubMed ID: 21678977
[TBL] [Abstract][Full Text] [Related]
19. The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.
Khan J; Rades T; Boyd B
Pharm Res; 2016 Mar; 33(3):548-62. PubMed ID: 26597939
[TBL] [Abstract][Full Text] [Related]
20. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
Mohsin K
AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
